Association of HPC2/ELAC2 genotypes and prostate cancer.
about
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerMeta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancerMolecular pathology of prostate cancerA candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonucleaseThe N-terminal half-domain of the long form of tRNase Z is required for the RNase 65 activityMutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancerMolecular genetics of human prostate cancer.Genetics of prostate cancer.Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up StudyA genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.Genetics of prostate cancer: too many loci, too few genesHPC2 variants and screen-detected prostate cancerDisease variants in genomes of 44 centenarians.Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomesReferral for cancer genetics consultation: a review and compilation of risk assessment criteriaA Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of CancerGermline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancerSegregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of diseaseAffinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNAA common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.Mutations in CHEK2 associated with prostate cancer risk.Analysis of the RNASEL gene in familial and sporadic prostate cancer.Molecular pathways in prostate cancer.Association of VDR polymorphisms ( Taq I and Bsm I) with prostate cancer: a new meta-analysis.ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.Polymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer.Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.ElaC encodes a novel binuclear zinc phosphodiesterase.Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population.Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.Producing knowledge about racial differences: tracing scientists' use of "race" and "ethnicity" from grants to articles.Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer
P2860
Q24536433-2AAAF3EE-80E5-47F9-B5CE-E2B7276E4FD0Q24615779-CE06A5EE-0F83-4603-AC75-8A3A60C4D2C8Q24672410-1FFD3EB6-38E2-4C54-A20F-0EED08D547D2Q24678249-F8DE7E96-E58A-4DA4-AD38-FCEB8BC09360Q28116099-1FCD9353-1812-4899-ADB8-DF6904C0FBFDQ28236153-A0688ED1-2AD3-4D05-8481-22195360B247Q31039228-ADAECEB4-95CA-4FE4-823F-23F547FB675DQ33723275-31340BA6-4D6B-4738-853A-6B2FD27E7B25Q33898895-722AFDE5-88C1-4B68-A14E-D85F520F9842Q33986279-44B5FB63-7ECD-4A68-8977-405A47588C58Q34020369-9D11E3AC-6286-47C7-9AC3-FCEBCC5DC799Q34020687-2AD1C997-A7DE-4784-B0F3-B877FC925E3FQ34020691-C211699A-EC03-4851-A538-F81B3F75B408Q34078064-8172D4A1-52A2-4944-9CDC-2FEA1D456390Q34114671-1CEF47CD-37C7-4456-8274-6A9012404CFFQ34311136-396E0C52-ECB8-4F00-AA34-B2DE8FA7C09EQ34722941-2CD2CBF1-B726-4953-A55F-C0CCB00863F7Q35444793-B9B6ECC8-752E-4DE3-B598-36971B3503ACQ35737508-D45A73FD-3EBB-4D08-8FF9-D05DB2094575Q35764687-6B0BEEC3-512E-4438-ABB1-505EF3AA5B1FQ35933901-99D9647B-F2F9-4B99-BF55-524196E55B9BQ36430744-D6D46D23-C265-45A7-AE72-2F8C150C90D9Q36604157-DFEBC133-DA80-4968-9D35-3626F621DCDAQ36643361-3A89334E-2EAB-4062-ADAC-C722DB9B6EB7Q36646188-EF102421-0EE9-4063-813C-F5E874271044Q36910780-D85C6240-CC37-4126-8051-89BA3C1413D2Q36930090-4D5AEF5D-46E4-4AD2-B21A-FFA6FE329E3AQ37219438-D4106C9E-EC41-4B3F-B714-DCCB77A98754Q37361805-32B2A004-7EE1-479A-B43C-036CEE3803B1Q38166735-E5A1AC0E-19F9-4A26-A069-CDBB88F34A3DQ38754850-77F75C0E-3B78-41BF-AAF1-EDE1DAE40B76Q41880985-E8405F8B-DBFA-4A95-BE6C-FAA8F5E5EAF6Q42074129-3D9B55B3-A239-4877-B017-2180160BD965Q42231048-F2263F10-FA02-4A4D-BF51-7CB91CFD81FBQ44005234-6BCC1AA2-D1F4-4E41-A2A6-AD62B528C509Q44402907-1C4CD640-5E3D-43E8-AC17-CFB59C692860Q44618467-FAD61514-D742-4501-B628-B2522BE3C64EQ50767550-CAFE00A1-9A60-41BF-B0E1-5D74AFB868F2Q52566012-5033356B-F276-47A1-9020-5E3481C15BCCQ57307289-477A51CD-B2DC-4C8C-8E18-C847C1CF986E
P2860
Association of HPC2/ELAC2 genotypes and prostate cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Association of HPC2/ELAC2 genotypes and prostate cancer
@nl
Association of HPC2/ELAC2 genotypes and prostate cancer.
@ast
Association of HPC2/ELAC2 genotypes and prostate cancer.
@en
type
label
Association of HPC2/ELAC2 genotypes and prostate cancer
@nl
Association of HPC2/ELAC2 genotypes and prostate cancer.
@ast
Association of HPC2/ELAC2 genotypes and prostate cancer.
@en
prefLabel
Association of HPC2/ELAC2 genotypes and prostate cancer
@nl
Association of HPC2/ELAC2 genotypes and prostate cancer.
@ast
Association of HPC2/ELAC2 genotypes and prostate cancer.
@en
P2093
P2860
P356
P1476
Association of HPC2/ELAC2 genotypes and prostate cancer
@en
P2093
A H Walker
A M Martin
S B Malkowicz
S Weisburg
T R Rebbeck
P2860
P304
P356
10.1086/303096
P407
P577
2000-09-12T00:00:00Z